25.43
-0.31 (-1.2%)
-0.31 (-1.2%)
Upgrade to Real-Time
Regular Market
Low
17.96
High
63.69
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.31 | -1.2% | 25.43 | 11:15:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 25.67 | 24.9888 | 26.50 | 25.74 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 25.45 | 26.51 | 1.06 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 122 | 5,918 | $ 25.74 | $ 152,315 | - | 17.96 - 63.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:15:05 | 1 | $ 25.56 | USD |
Period:
Draw Mode:
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 521.94M | 20.52M | 8.80M | $ - | $ - | -4.52 | -6.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 111.01k | 7.50% |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 26.15 | 26.53 | 24.78 | 25.72 | 37,505 | -0.72 | -2.75% |
| 1 Month | 30.01 | 30.8499 | 24.78 | 28.29 | 50,841 | -4.58 | -15.26% |
| 3 Months | 29.91 | 39.08 | 24.78 | 30.44 | 72,761 | -4.48 | -14.98% |
| 6 Months | 40.63 | 42.70 | 24.78 | 31.47 | 52,340 | -15.20 | -37.41% |
| 1 Year | 18.30 | 63.69 | 17.96 | 34.16 | 70,541 | 7.13 | 38.96% |
| 3 Years | 18.30 | 63.69 | 17.96 | 34.16 | 70,541 | 7.13 | 38.96% |
| 5 Years | 18.30 | 63.69 | 17.96 | 34.16 | 70,541 | 7.13 | 38.96% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
